论文部分内容阅读
采用定量ELISA双抗体夹心法测定慢性支气管炎患者血浆SE－SL含量为51．23±12．09μg／L，正常对照组为32．04±9．75μg／L，两者比较差异非常显著（P＜0．01）：其中急性加重期与缓解期，治疗前与治疗后比较均有显著差异（P＜0．01），提示血浆SE－SLT测定为临床观察病情、判断疗效及预后提供了一个重要参考指标。
Quantitative ELISA double antibody sandwich method for the determination of serum levels of SE-SL in patients with chronic bronchitis was 51.23 ± 12.09μg / L, the normal control group was 32.04 ± 9.75μg / L, the difference was significant (P <0.01): There was a significant difference (P <0.01) between acute exacerbation and remission, before treatment and after treatment, suggesting that the determination of plasma SE-SLT provides a clinical observation of the disease, to determine the efficacy and prognosis Important reference indicators.